Cancer Trials Ireland is delighted to announce that Professor Seamus O’Reilly has been appointed as Vice-Clinical Lead (VCL) for the organisation. He will take up the position in January 2021. Until then, Cancer Trials Ireland can accept correspondence on behalf of Professor O’Reilly, in his capacity as the incoming VCL. Emails to email@example.com. Please mark any mails for his attention.
Professor O’Reilly said:
“In the past 2 decades cancer care has been transformed in Ireland. Cancer Trials Ireland and it’s predecessor ICORG have been an important cohesive force in this transformation – catalysing inter-hospital and interdisciplinary collaboration leading to access to cutting edge cancer treatments in our communities. I’m delighted to accept this important clinical leadership role and look forward to helping deliver new therapies to patients and improving cancer care in the next decade.”
Prof O’Reilly graduated in Medicine from the National University of Ireland in Galway and completed Medical Oncology training and PhD at the Johns Hopkins Hospital. Post fellowship he was an Associate Professor there specialising in Cancer Pharmacology. In 1998 he established a Medical Oncology programme and Cancer Clinical trials unit at Waterford University Hospital and subsequently moved in 2001 to Cork University Hospital establishing a Medical Oncology programme and a Health Research Board funded clinical trials unit there.
In 2014 he was appointed as associate Professor at University College Cork and since 2013 has been co National Director in Medical Oncology at the Royal College of Physicians in Ireland. He is a founding trustee and co Chairperson of Cork ARC Cancer Support House. He has been Disease Specific Lead in Gastrointestinal Cancers at Cancer Trials Ireland and is co-author of over 100 peer reviewed publications.